We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First COPD Trial with RPL554 Begins in Rome

Product News   Apr 14, 2011

 
First COPD Trial with RPL554 Begins in Rome
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

Product News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

READ MORE

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Vaccine Against COVID-19 Advances to Late-stage Development

Product News

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE